Radiation treatment for colon cancer in the liver using tiny beads
Part of Cancer, Digestive system clinical trials.
This trial studies a targeted liver radiation procedure that uses tiny radioactive beads to treat colon cancer spread mostly in the liver. It may help people whose liver tumors cannot be removed or treated with other common local treatments, but it has several safety and “screening” checks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have colon cancer that has spread to the liver, mostly in the liver, and you cannot have the liver tumors removed (surgery) or treated with RFA or SBRT
- Your cancer has continued to grow or you could not tolerate standard chemotherapy options
- You must be 18 or older and able to understand the study information and consent
- Your daily function should be good (ECOG 0–1), meaning you’re able to do self-care and most daily activities
- You must have stopped chemotherapy for 14 days and stopped VEGF-targeted medicines (for blood vessels) for 6 weeks before the procedure
- Your liver and bile levels and other safety blood tests must be within limits before treatment, and you must not have an infection that’s not under control
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies giving targeted high-dose radiation (SBRT) to liver metastases from colorectal cancer after initial treatment, with the goal of improving long-term control or cure. It may help people who have a limited number of liver spots that doctors think can be treated safely and effectively.
This trial tests combining focused radiation (SBRT) with immunotherapy for colorectal cancer that has spread to the liver or lungs. The goal is to see if this combination can shrink tumors and improve control of the cancer.
This trial tests two procedures—irreversible electroporation and stereotactic body radiotherapy—for people whose colorectal cancer has spread to the liver (1–3 tumors near major blood vessels or bile ducts) and can't be surgically removed or treated with heat. The goal is to see if these approaches can safely destroy those hard-to-reach tumors.
This trial tests a combination of treatments for people with colorectal cancer that has spread to the liver and cannot be removed by surgery. It uses an oncolytic virus (which infects and kills cancer cells) along with radiation, chemotherapy, targeted therapy, and immunotherapy to try to shrink the liver tumors.
This trial tests a treatment that delivers tiny radioactive beads directly to liver tumors to shrink them, which may help patients become eligible for a liver transplant or surgery. It is for people with liver cancer that has not spread outside the liver.
This trial tests a new treatment called DaRT (alpha radiation seeds) implanted directly into liver tumors that have spread from colorectal cancer. The seeds deliver targeted radiation to shrink tumors while reducing damage to healthy liver tissue, as part of a two-stage surgical plan.
Hear when a new Liver Metastasis Colon Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.